Integrin Beta1-mPA-GFP
(Plasmid
#186302)
-
PurposeExpresses mPA-GFP tagged Integrin beta-1 in mammalian cells on a CMV promoter
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 186302 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneClontech N1
- Backbone size w/o insert (bp) 4000
- Total vector size (bp) 7213
-
Vector typeMammalian Expression, Bacterial Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameIntegrin Beta 1
-
Alt nameITGB1
-
Alt nameCD29
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2394
-
GenBank IDNM_002211.3
-
Entrez GeneITGB1 (a.k.a. CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB)
- Promoter CMV
-
Tag
/ Fusion Protein
- mPA-GFP (C terminal on insert)
Cloning Information
- Cloning method Unknown
- 5′ sequencing primer CMV-F
- 3′ sequencing primer SV40pA-R (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Photoconvertable:
On: Excitation 504 nm, Emission 517 nm
Off to On: 400 nm
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
Integrin Beta1-mPA-GFP was a gift from Pakorn Kanchanawong (Addgene plasmid # 186302 ; http://n2t.net/addgene:186302 ; RRID:Addgene_186302) -
For your References section:
Ligand functionalization of titanium nanopattern enables the analysis of cell-ligand interactions by super-resolution microscopy. Jain K, Kanchanawong P, Sheetz MP, Zhou X, Cai H, Changede R. Nat Protoc. 2022 Jul 27. pii: 10.1038/s41596-022-00717-3. doi: 10.1038/s41596-022-00717-3. 10.1038/s41596-022-00717-3 PubMed 35896742